Skip to content
The Nexus
DossierENTITY

Max Hodak

Coverage of Max Hodak in the Nexus archive.

Earliest in view: Apr 14 · 17:13 UTCMost recent: Jul 22 · 10:00 UTC
Co-mentioned in this coverage
Neuralinkorganization2Science Corporganization2Scienceorganization1Age-related macular degenerationtopic1retinal implanttopic1European regulatorsorganization1Artificial Intelligencetopic1Chinaplace1United Statesplace1brain-computer interfacestopic1macular degenerationtopic1organ transplantstopic1hybrid sensortopic1human trialstopic1
Recent coverage
  • HEALTHJul 22 · 10:00 UTCSTAT NEWS
    STAT+: ‘Cochlear implant for blindness’ debuts in Europe, could launch in U.S. in 2027

    A retinal implant approved in Europe can partially restore vision for patients with age-related macular degeneration, potentially improving reading and road sign visibility. The device, developed by Science Corporation, may launch in the U.S. in 2027. CEO Max Hodak described it as a 'cochlear implant for vision.'

  • TECHNOLOGYJun 16 · 07:00 UTCSCIENTIFIC AMERICAN
    Max Hodak

    Max Hodak, the Neuralink co-founder, discusses artificial intelligence as the new industrial revolution. The article highlights his perspective on AI's transformative potential.

  • TECHNOLOGYJun 11 · 02:25 UTCSEMAFOR
    A Sputnik moment: China's beating the US in neuroscience

    Max Hodak warns the US risks losing neuroscience leadership to China, which has approved its first commercial BCI and made it a national priority. Science Corp is developing retinal implants for macular degeneration and organ preservation tech for transplants.

  • SCIENCEApr 14 · 17:13 UTCTECHCRUNCH
    Max Hodak’s Science Corp. is preparing to place its first sensor in a human brain

    Max Hodak’s Science Corp is set to deploy its first hybrid sensor in a human brain, with human trials anticipated to commence in the near future. The development marks a significant step in brain-sensing technology.